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IMMUNOLOGICAL STUDIES OF MOUSE DECIDUAL CELLS 
I.  Membrane Markers of Decidual Cells 
in the Days after Implantation* 
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DOROTHEA  BENNETT 
(From the Memorial Sloan-Kettering Cancer Center, New York 10021) 
The mechanisms by which the mammalian embryo is protected from allograft 
rejection by the mother remain unclear at present although several hypotheses 
have been brought forward (1-3).  Recent advances seem to favor the lack of 
detectable transplantation antigens on the postimplantation trophoblast (4, 5) 
and of blocking antibodies (6). On the other hand, the decidua in the pregnant 
uterus may provide a locally privileged environment to the embryo (7, 8). For 
example, extracts from artificially induced decidua have been shown recently  to 
possess immunosuppressive properties (9). 
Little is known of the exact role or origin of the decidua that develops and 
surrounds  the  postimplantation  embryo in  the  pregnant  uterus  (10). Most 
decidual cells  seem to  be  derived from uterine  stroma cells  that  resemble 
embryonic  fibroblasts (11, 12), but morphological data have suggested that some 
of the cells present in mouse and rat decidua may be lymphocytes or derived 
from lymphocytes (13, 14). Moreover, recent data show that immunoglobulin- 
containing cells are present in the mouse decidua shortly aider implantation 
(15) as well as in the rat metrial gland at a later stage (16). 
We report here the results of an attempt to define immunologically the cells 
of the  mouse decidua in  the  days after implantation.  It  is  shown  that,  in 
addition to H-2 antigens, Thy-1 antigen can be detected on a sizable fraction of 
decidual  cells  and  that  an  apparently  increasing  number  of cells  bearing 
receptors for the Fc portion of immunoglobulin G can be detected in the decidua 
as pregnancy proceeds from day 6 to day 8. 
Materials and Methods 
Mice.  Mice from various inbred and outbred strains were used. C57B1/6  (B6) were purchased 
from Charles River Breeding Laboratories,  Wilmington,  Mass.,  The Jackson Laboratory,  Bar 
Harbor, Maine, or came from Dr. E. A. Boyse's colony at Sloan-Kettering Institute. Females from 
congenic strains for Lyt-1, Lyt-2, Lyt-3, and Lyt-4 (Ly-5) came from Dr. E. A. Boyse's colony. A/J, 
AKR/J,  and C3H/HeJ mice were purchased from The Jackson Laboratory. Random-bred CF1 or 
ICR albino mice were also used.  Inbred, hybrid, or outbred matings were set up, and the day a 
vaginal plug was found was considered day 0 of pregnancy. 
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Preparation of  Decidual Cells.  Primiparous females were killed by cervical dislocation at 6, 7, 
and 8 days. Decidual capsules were dissected out of the uterus and placed in medium consisting of 
Dulbecco's phosphate-buffered  saline with calcium (Grand Island Biological Co., Grand Island, 
N. Y.), supplementedwith 0.3% fructose and 0.3% dextrose. All steps of decidual cell preparation 
were carried out in the same medium. Each capsule was checked for the presence of a  normally 
developed embryo, and the whole embryo and its immediate surroundings  (remnants of uterine 
epithelium, Reichert's membrane, and trophoblast) were removed as completely as possible under 
a  dissecting microscope. Only decidua actually containing a  healthy looking embryo were used 
further in the preparation of decidual cells. Capsules from one or two litters were chopped with 
scissors  in cold  medium and transferred  to  20  ml of  I mg/ml collagenase type II (Sigma Chemical 
Co., St. Louis,  Mo.) containing 5 ~g/ml RNASe free-DNAse I (Worthington Biochemical Corp., 
Freehold, N.J.) in medium. Pieces of  decidua were incubated in collagenase for  20 rain  at 37°C, 
then  washed twice in  medium, and incubated sequentially  for  four  to  eight  5-rain  periods  in i  mg/ 
ml trypsin (1:250;  Difco Laboratories, Detroit, Mich.) in medium containing 5 pg/ml DNASe. 
Trypsin was previously allowed to dissolve in medium for 30-60 rain  at room temperature and 
filtered  just before use.  Each 5-rain  incubation in trypsin was followed by gentle pipetting for  3 
min in siliconized  Pasteur pipettes.  Supernates of  each incubation period were filtered  through a 
37-/~m nylon gauze  mesh into  medium containing 20% heat-inactivated,  gammaglobulin-free fetal 
calf serum (IPT)  1 and 5 ~g/ml DNAse. Cells were spun at 250 g  and resuspended in 20% IPT and 
5  ub/ml  DNAse  in  medium.  Cell viability was  assessed  by trypan  blue  exclusion.  Fractions 
containing >  90% viable cells were pooled and used for tests. This usually involved fractions 2 to 
5  or 6,  except for decidual  cell cultures  where  fractions  2  to  8  were  used.  The  first  fraction 
contained numerous  erythrocytes,  and  viability of nucleated  cells was  less good.  Under these 
conditions, one 7-day litter containing 6-10 capsules averaged a yield of 1.5-2.5  x  10  e cells. 
Sera.  A anti-B6 leukemia EL4, an anti-H-2  b serum, was absorbed in vivo in B10.A or B6 mice 
before  use  and  was  a  giR of Dr.  E.  A.  Boyse.  Titer of this  serum  in  complement-dependent 
cytotoxicity on B6 lymph node cells is over 1/1,600. 
(A-Thy-l.1 x  AKR-H-2b)F1  anti-A strain leukemia ASL1, an anti-Thy-l.2 serum, was absorbed 
twice on the AKR tumor,  K36, to remove autoantibodies.  After these two absorptions,  its titer, 
when tested in complement-dependent cytotoxicity on A/J thymocytes, is 1/50,000.  Experimental 
absorptions  of anti-Thy-l.2  serum on A/J or AKR/J thymocytes,  respectively, were performed 
with 0.1 ml of serum diluted 1:100 and 20 x  10  ~ thymocytes for 45 min at +4°C. 
Anti-Lyt sera  (anti-Lyt-l.2,  anti-Lyt-2.2,  anti-Lyt-3.2,  and  anti-Lyt-4.1)  were prepared  and 
absorbed as described (17). Anti-Lyt-2.2 serum was further absorbed once on the tumor K36 (vol/ 
vol, at a 1:2 dilution of serum). 
Complement-Mediated  Cytotoxicity.  Pooled decidual cells were pelleted and resuspended  in 
medium 199 without serum at a  concentration of 1.5  x  106 cells/ml. 25 pl of cell suspension was 
incubated for 45 rain at 37°C with 25 ~al of one of the various dilutions of serum to be tested and 25 
~1 of a 1:4 dilution of rabbit complement previously absorbed on mouse ter.atoma F9 cells (18). The 
number of live cells was assessed by trypan blue exclusion and results expressed as cytotoxicity 
index: 
percentage of  dead cells  incubated in  serum and complement 
-  percentage of  dead cells  in  complement alone 
100 - percentage of  dead  cells  in  complement alone 
Percentages of dead cells in complement controls averaged 20%. 
Culture  of Decidual  Cells.  Pooled  decidual  cells  aRer  trypsin  treatment  were  spun  and 
resusponded  in Dulbecco's modified Eagle's minimal essential medium supplemented with 15% 
fetal calf serum and antibiotics, transferred to plastic Falcon culture dishes (Falcon Plastics, Div. 
1  Abbreviations used in this paper:  B6, C57BL/6; BSS, balanced salt solution; CR, receptor for 
complement components;  E  rosette,  rosette  with  nonsensitized  SRBC; EA,  sheep erythrocytes 
coated with 7S anti-SRBC antibody; EAC, sheep erythrocytes coated with 19S anti-SRBC antibody 
and mouse complement; FcR, receptor for Fc portion of IgG; IPT, heat-inactivated, gammaglobu- 
lin-free fetal calf serum; PBS,  phosphate-buffered  saline,  pH 7.4;  sIg, surface immunogiobulin; 
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of BioQuest,  Oxnard,  Calif.)  at  a  concentration of 1.5  ×  108  cells per dish  and  placed  in  an 
incubator at 37°C  under 12%  CO2.  A~er 16-24 h,  attached cells were washed twice in calcium- 
magnesium-free Earle's balanced salt solution (BSS), detached from the dish with 2 mM disedium 
EDTA in 2% chicken serum for 5 rain at 37°C  followed by pipetting.  Cells were transferred to 
Hanks'  BSS  supplemented  with  5%  IPT  and  washed  twice  in  this medium.  Viability of the 
resulting cell suspension, as judged by trypan blue exclusion, averaged 80%. 
Rosette Studies.  EA and EAC  rosette studies were performed on decidual cell suspensions 
aider enzyme treatment or on decidual cells recovered alter culture (19).  Briefly, sheep erythro- 
cytes (SRBC),  2 wks old, were sensitized with either rabbit 7S anti-SRBC  (Cordis Laboratories 
Inc., Miami, Fla.) (EA), or rabbit 19S anti-SRBC (Cordis Laboratories) and AKR/J mouse serum 
as a  source of complement (EAC). 0.3 ml of decidual cell suspension at a  concentration of 2.5  × 
106/ml and 0.3 ml of EA or EAC was incubated at 37°C for 3 rain after centrifugation at low speed 
(EA)  or  for  30  rain  without  centrifugation  (EAC).  Controls  were  run  simultaneously  with 
nonsensitized SRBC (E rosettes). Cells were then left for at least 1 h at +4°C, and rosette-forming 
cells were counted in a hemocytometer, nucleated cells being stained by toluidine blue. At least 
500 nucleated cells were counted in each sample, and the percentage of rosette-forming cells was 
established. This technique was also used for B6 or CF1 female spleen cell suspensions. Spleen 
cells were prepared either by chopping and pipetting in Hanks' BSS supplemented with 5% IPT or 
by collagenase and trypsin treatment of pieces of spleen as described in decidual cell preparation, 
to test the effect of enzyme treatment on EA or EAC rosette-forming cells. In one instance, spleen 
cells were  treated  with  Ca  ++  Mg++-free  Earle's BSS  and  2  mM  disodium  EDTA,  followed  by 
washes in Hanks' BSS with 5% IPT, as for cultured decidual cells, to study the possible role of this 
EDTA pretreatment on EAC rosettes. 
In addition to E, EA, and EAC rosettes, the effect of EDTA during EAC rosette formation was 
tested on complement receptor-bearing spleen cells by adding 30 ~l of 0.2% buffered EDTA to 
EAC rosette incubation medium. 
Surface  lmrnunoglobulins  (sIg).  1-2  ×  l0  s  decidual  cells  were  resuspended  in  0.1  ml  of 
peroxidase-labeled sheep Fab anti-mouse immunoglobulin (Institut Pasteur, Paris) diluted 1:20 in 
Hanks' BSS containing 5% IPT and incubated for 1 h at +4°C. 
Cells were then washed three times in Hanks' BSS and IPT,  fixed in 2% glutaraldehyde  in 
phosphate-buffered saline for 15 min at  +4°C,  washed three times in phosphate-buffered saline 
and stained for peroxidase activity for 3 rain at room temperature in diaminobenzidine tetra HC1 
(50 mg/100 ml-in  Tris HCI; pH 7.4) and 0.01% H=O2. sIg-bearing cells, which appear surrounded 
by a  brown layer, were counted in a  drop of cell suspension or after cytocentrifugation. Possible 
presence of endogenous peroxidase activity was tested by incubating decidual cells in Hanks' BSS 
and IPT in lieu of peroxidase conjugates.  Further positive and negative controls, respectively, 
were done with spleen cells and thymocytes, under the same conditions. In some instances, spleen 
cells were first treated with collagenase and trypsin as described in decidual cell preparation, to 
check the possible role of trypsin on sIg detection under the conditions we used. 
Results 
Decidual  Cell Suspension.  Cells  from  6-,  7-,  and  8-day  decidua  were 
examined  in  suspension  under  the  light  microscope,  to  study their  size  and 
appearance.  80-85% of nucleated cells present in the preparation were made up 
of round cells, 10-15/~m in diameter.  Staining with hematoxylin aiter fixation 
in glutaraldehyde  and cytocentrifugation showed these cells to be olden bi- or 
multinucleated.  They are assumed to be mostly decidual cells proper.  Larger 
cells, 20-30 ~m in diameter, were 2-5% of the total. In addition, smaller cells, 7 
~m in diameter when in suspension,  averaged 10-15% of the cell preparation. 
These  were  round  and  mononucleated,  like  small  lymphocytes.  Erythrocyte 
counts showed only 50 erythrocytes per 100 nucleated cells. Inasmuch as, in the 
mouse, the average leukocyte cell count is 104 per cubic millimeter of blood and 
the  average  erythrocyte  cell  count  107  per  cubic  millimeter,  virtually  no 
circulating  leukocytes appear to be present  in the decidual cell preparations. O.  BERNARD,  M.  P.  SCHEID,  M-A.  RIPOCHE,  AND  D.  BENNETT  583 
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Fro. I.  Titration on 7-day B6 female  x  A/J male decidual cells of A  anti-EL4 serum 
absorbed in vivo  on B10.A (0) and B6 (<3). 
The  presence  of cells  other  than  decidual  cells  proper  cannot  be  excluded, 
however, especially leukocytes that could cress the blood barrier and be present 
in the decidua. 
Decidual Cell Membrane Antigens 
1.  H-2  ANTIGENS.  Studies of H-2 antigens were done on 7-day pregnant B6 
mice sired by B6 or A/J males. Fig. i  shows that H-2 antigens, as detected by A 
anti-EL4 serum absorbed in vivo on B10.A, are present on most decidual cells. 
No activity is detectable when the same serum is used after absorption in vivo 
on B6. 
2.  THY-1  ANTIGENS.  Anti-Thy-l.2 serum was used in complement-dependent 
cytotoxicity tests on decidual cells from B6 females x  A/J males and AKR/J x 
AKR/J matings at 6, 7, and 8 days. Fig. 2 shows the results of experiments done 
at 7 days. 45% of B6 decidual cells available for killing express Thy-l.2 antigen 
when serum is used at 1:100 dilution. Absorption on A/J thymocytes removes all 
activity,  whereas  absorption  on  AKR/J  thymocytes leaves  activity  virtually 
identical. No activity could be detected when anti-Thy-l.2 was tested on AKR/J 
decidual cells.  6- and 8-day B6 decidual cells also express Thy-1,  in a  similar 
amount  at  8  days  (cytotoxicity index  at  1:100=0.4)  and  in  somewhat higher 
proportion  at 6 days (cytotoxicity index at 1:100=0.6).  The morphology of the 
dead cells can easily be studied because they are stained by trypan blue. Most of 
the dead cells looked like typical medium-size or large, granular,  sometimes bi- 
or multinucleated decidual cells. 
3.  LYT ANTIGENS.  All four anti-Lyt sera were first tested without absorption 
on K36 for complement-dependent cytotoxicity on B6 decidual cells and on the 
decidual  cells of the  four strains  congenic  for  Lyt antigens.  In two separate 
series of experiments with each of the anti-Lyt sera,  only minor and variable 
differences (never exceeding 0.1) could be detected between cytotoxic indices on 
B6 and  congenic decidual  cells  (data not shown).  The  highest difference was 
detected with anti-Lyt-2.2 serum.  However, further absorption of anti-Lyt-2.2 
on K36 removed all activity for B6 decidual cells but left intact activity for B6 
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Fro.  2.  Titration of anti-Thy-l.2 serum on 7-day decidual cells: B6 female  ×  A/J male 
decidual cells (0), AKR]J female × AKR/J male decidual cells (©),  B6 female × A/J male 
decidual  cells  after  absorption  on  AKR/J  thymocytes  (b)  or  after  absorption on  A/J 
thymocytes (ZX). 
Fc and Complement Receptors on Decidual Cells 
1.  Fc RECEPTORS (FcR).  Studies of EA rosette-forming cells in mouse decidua 
were done at day 6, 7, and 8 of pregnancy in B6 females mated with A/J males, 
C3H/HeJ females mated with C3H/HeJ males, and random-bred albino ICR or 
CF1 females mated with ICR males. Fig. 4 shows that FcR-bearing cells seem to 
be present  in  mouse decidua  in  increasing  numbers  as  pregnancy  proceeds. 
Virtually  all  EA  rosettes  consisted  of nucleated  cells  surrounded  by  12-15 
SRBC. The rosetted cells were 10-15 ftm in diamter, thus similar in size to most 
nonrosette-forming  decidual  cells  (Fig.  5).  Very  rarely  could  a  rosette  be 
observed with a cell the size of a small lymphocyte, such as the ones present in 
the spleen. Very large cells did not form rosettes. 
Because  it could be suggested that  some  EA rosette-forming  cells  were of 
embryonic origin (especially those closely connected with the decidua,  such as 
trophoblast  or  parietal  endoderm),  a  test  was  done  using  8-day  B6  x  A/J 
decidual cell preparation  after the embryo,  visceral yolk sac membrane,  and 
early placenta had been removed, but Reichert's membrane left intact as much 
as possible. Fig. 4 shows that this manipulation did not alter the percentage of 
EA rosette-forming cells.  Effect of time of sequential incubation  in trypsin on 
the  amount  of FcR-bearing  cells  in  resulting  decidual  cell  suspensions  was 
tested on 8-day B6  x  A/J and  CF1  x  ICR matings.  EA rosette-forming  cells 
were studied, separately pooling early fractions (2 to 4) and late fractions (5 to 
8).  Similar numbers of cells (about 1.5  x  10  8) were recovered in early and late 
fractions.  Fig.  4 indicates that,  in beth types of matings,  twice as many FcR- 
bearing cells were present in early fractions as compared with late fractions. 
2.  COMPLEMENT RECEPTOR (CR).  No  EAC  rosette-forming  cells  could  be 
detected on decidual  cell suspensions  tested immediately after enzyme treat- 
ment.  Because most CR are trypsin sensitive  (20 and Table I),  the conditions 
used in the preparation  of decidual cells could have accounted for the lack of 
detectable EAC rosette-forming cells. Therefore decidual cells were cultured for 
16-20 h  to allow recovery of CR (21).  Table I  shows that no CR-bearing cells 
could be detected on attached cells released by EDTA treatment.  FcR-bearing 0.8 
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Fro.  3.  Titration of anti-Lyt-2.2 serum absorbed on K36: on B6 8-day decidual cells (O), 
on B6 thymocytes (O). 
cells  were  still  present  in  a  percentage  similar  to  that  just  after  trypsin 
treatment. 
Because  a  population  of EAC  rosette-forming  cells  in  the  spleen  is  also 
sensitive to EDTA (20; see also Table I), EA and EAC rosettes were studied on 
spleen  cells  pretreated  with  EDTA  as  described  in  Materials  and  Methods. 
Table I  indicates  that  EDTA pretreatment  did not alter the number of EAC 
rosette-forming cells. 
Surface Immunoglobulins (slg).  Under the conditions we used,  <1% of B6 
thymocyte cell membranes  were labeled by sheep Fab anti-mouse  Ig coupled 
with peroxidase,  whereas  40-50%  of B6 spleen cells were labeled.  Under the 
same conditions,  no sIg-bearing cell could be detected among decidual cells in 
five  separate  experiments  involving  various  mating  combinations  (AKR  x 
AKR,  C3H  x  AKR,  CF1  x  ICR,  ICR  x  ICR)  at  7  and  8  days of gestation. 
Endogenous peroxidase was present in a  few cells as cytoplasmic granules.  To 
study the possible role of enzyme treatment  to explain the lack of detectable 
sIg, a suspension of spleen cells was treated by collagenase and trypsin as used 
for decidual cell preparation.  In two separate experiments,  enzyme treatment 
did not alter the number of detectable sIg-bearing cells in the spleen. 
Discussion 
Studies of membrane  markers  on mouse decidual cells as presented in this 
report indicate that, besides H-2 antigens,  approximately 50% of decidual cells 
possess Thy-1 antigen,  and that a seemingly increasing number of cells possess 
FcR. On the other hand,  cell membrane markers such as sIg, four different Lyt 
antigens,  and complement receptors were not detected under the conditions we 
used. 
Thy-1 antigen was previously described on mouse thymocytes (22), peripheral 
T  lymphocytes (23),  brain  cells  (24,  25),  epidermis  (26),  fibroblasts in culture 
(27),  mammary tissue  (28),  and,  at an early stage, in differentiation of muscle 586  MEMBRANE  MARKERS  OF  MOUSE  DECIDUAL  CELLS 
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Fro.  4.  EA rosette-forming cells in mouse decidua from day 6  to day 8  of pregnancy. 
Fractions used for tests were fractions 2 to 5 or 6 unless otherwise mentioned. (O) B6  x 
A/J,  C3H  x  C3H,  and CF1 or ICR  x  ICR matings. No significant strain difference was 
observed  among  these  three  mating  combinations  (&,  mean  of figures  observed  and 
standard deviation); (0) corresponding  controls using unsensitized SRBC and decidual cells 
(E rosette); (x) B6  x  A/J, without dissecting out Reichert's membrane; (&) B6  x  A/J or 
CF1  x  ICR mating, fractions 2 to 4 only; (A) B6 x  A/J or CF1 x  ICR mating, fractions 5 to 
8 only. 
cells in culture (29). It is possible that expression of Thy-1 antigen on about 50% 
of mouse  decidual  cells  as  detected  here  reflects  their  fibroblastic  origin; 
development of decidual cells from uterine stromal cells was suggested from 
morphological as well as autoradiographic observations  (11,  12). Thy-1 being 
detectable on mouse fibroblasts in vitro,  it can be suggested that,  as uterine 
fibroblast  undergo division and differentiatiqn into  decidual cells,  a  fraction 
retains some features of  their stromal origin. This might account for the slightly 
decreasing percentage of Thy-l-positive decidual cells as time proceeds. Prelim- 
inary observations indicate that, in artificially induced mouse decidua, 60-70% 
of the cells bear Thy-1 at day 6 of pseudopregnancy, a  figure quite similar to 
that observed at day 6 of normal gestation in mice (O. Bernard, unpublished 
observations). Therefore, expression of Thy-1 on decidual cells does not depend 
on the actual presence of an embryo. Alternatively, it could be suggested that 
Thy-1 is a  marker of some fully differentiated decidual cells, the expression of 
which could be under hormonal control.  The role of Thy-1 antigen in mouse 
decidua remains largely a matter of speculation. Heterologous anti-thymocyte 
serum was reported to prevent normal implantation and/or early development 
in mice and rats (30, 31). Whether specific anti-Thy-1 serum can also reproduce O.  BERNARD,  M.  P.  SCHEID,  M-A.  RIPOCHE,  AND  D.  BENNETT  587 
Fro. 5.  EA rosette-forming and non_forming cells  in  8-day mouse decidua (x 720). 
this effect is not known at present but could possibly relate successful blastocyst 
implantation to the presence of Thy-l-bearing uterine cells undergoing deci- 
dualization. 
Results presented here showing the absence of Lyt antigens and sIg do not 
support the idea that T or B lymphocytes are present in significant numbers in 
the  mouse  decidua  in  the  days  after  implantation.  It  should  be  stressed, 
however,  that  lymphocytes might exist  in  the  more  internal  layers of the 
decidua, closest to the embryo, which were selectively removed with the first 
cell fraction after 5 min of trypsin treatment. Alternatively, T cells present in 
the decidua could bear some other known, or as yet unknown, Lyt phenotypes. 
In any case, the lack of detectable Lyt antigens cannot be the result of trypsin 
treatment because it was previously ~hown that,  like H-2  and Thy-1, these 
antigens are resistant to trypsin under conditions similar to those used in this 
study (26). The same comment can be made about lack of detectable sIg-bearing 
cells: identical enzyme treatment of mouse spleen did not alter the percentage 
of sIg-bearing cells in the spleen. The most likely hypothesis to account for the 
absence of both Lyt and sIg is that in the decidua proper virtually no "classic" T 
or B lymphocytes can be detected in significant amounts under the conditions 
we used. 
However, FcR-bearing cells are present in apparently increasing numbers 
from day 6 to day 8 of gestation. It could be argued that this increase is partially 
owing to the increasing size of the decidual capsules, therefore allowing more 
decidual cells from superficial layers to be present in a given cell preparation at 
8 days; as  seen in Fig.  4,  external layers of the decidua contain more FcR- 
bearing cells at 8 days than do deeper layers. The latter difference could merely 
be  the  consequence of increased  sensitivity  of FcR  to  trypsin  as  time  of 
incubation in trypsin is prolonged. However, it is likely that these external, 
FcR-bearing cells correspond to Ig-containing cells detected by immunohisto- 
chemical methods in sections of postimplantation mouse decidua (15) and in rat 
metrial glands at 12 days of gestation (16). In the days after implantation, Ig- 
bearing cells in mouse decidua are present mostly in two areas: (a) in the outer 
layers, facing the myometrium  where Ig appear as cytoplasmic granules and (b) 588  MEMBRANE  MARKERS  OF  MOUSE  DECIDUAL  CELLS 
TABLE  I 
E, EA, and EAC Rosette-Forming Cells 
Decidual  cells*  Collagen- 
ase-  and  EDTA-pre-  Untreated 
trypsin-  treated spleen  cellsll 
7  day  8  day  treated spleen  cells§ 
spleen  cells~ 
% 
E rosettes  0  0  1.5  0.9  0.3 
EA rosettes  10  16  39  39  37 
EAC rosettes  0.5  0  2.5  25  23 
EAC rosettes with Na EDTA  ND  ND  ND  11  14 
*  CF1 x ICR 7  and 8-day  decidual  cells  left  in  culture  for  16-20  h and released  from culture  dish 
with  2  mM Na EDTA. 
B6 female  spleen  cells  treated  with  collagenase  and  trypsin  (see  Materials  and Methods). 
§  CF1 female  spleen  cells  pretreated  with  2  mM EDTA (see  Materials  and Methods). 
II  CF1 female  spleen  cells  washed with  Hanks'  BSS with  5% IPT  in  lieu  of  each  step  of  EDTA pre- 
treatment. 
ND: not  done. 
in the inner layers, facing the embryo, where Ig can be detected between each 
decidual cell  or, possibly, on the cell  membrane  proper (15).  If, as we suggest, 
FcR-bearing cells  are actually located in these two areas of  Ig-containing cells, 
it is to be expected that they will be chiefly recovered in the first  cell  fractions 
when pieces of  decidua are sequentially incubated in trypsin. 
So far it must be said that, as much  as the biological role of the FcR on 
lymphocytes (as discussed in references 32 and 33) is still  a mystery, so, too,  is 
the functional significance of  FcR on decidual cells.  FcR may be merely used for 
the uptake of circulating Ig as a means of nutrition for the rapidly growing 
decidua,  or for clearing uterine  stroma  infiltrated with  Ig at the time  of 
implantation (15)  even though monomeric or free IgG in general is  more weakly 
bound  than  aggregate  Ig  or  antigen-complexed  Ig  (34,  35).  However,  it  is 
tempting  to  suggest  an  immunological  role  for  FcR-bearing  cells,  especially 
with respect to the maternal-fetal  relationship.  These cells might comprise a 
particular  class of lymphocytes with Lyt-negative,  sIg-negative,  FcR-positive 
phenotype, or could be macrophages with phagocytic properties, as described in 
the  12-day rat placenta  (36,  37).  However, lack of detectable CR, the fact that 
FcR-bearing cells can attach to culture dishes over a  period of 20 h  (Table I), 
and previously mentioned immunohistelogical  data indicate that FcR-bearing 
cells  are  probably  decidual  cells  proper  involved  in  some  as  yet  unknown 
interaction  with trophoblast,  maternal  tissues,  and/or  antigen-antibody  com- 
plexes. This interaction may be similar to that described for antibody-dependent 
cell-mediated cytotoxicity (38) or natural  cytotoxicity against tumor cells (39), 
and  may  prevent  trophoblasts  from  extensively  invading  maternal  tissues. 
Significantly,  when ectoplacental cones are transplanted  to the  uterus under 
conditions where no decidual  reaction  can be evoked,  a  massive invasion by 
trophoblast results (40). 
Alternatively, FcR-bearing decidual cells may contribute to protection of the 
embryo by binding maternal  (blocking?) antibodies and carrying them over to O.  BERNARD,  M.  P.  SCHEID,  M-A.  RIPOCHE,  AND  D.  BENNETT  589 
the  trophoblast where they could interact  with embryonic or transplantation 
antigens.  Resulting  antigen-antibody  complexes would be internalized  in the 
trophoblast (15, 41) or shed from trophoblast cell membrane and released in the 
circulation  (42,  43).  It  was  indeed  shown  that  the junctional  zone  between 
deeidua and trephoblast is often underlined by heavy deposits of Ig (15).  This 
could provide  an  explanation  for the  apparent  protection  afforded to  skin  or 
blastocyst transplanted  in allogenic uteri in rats and mice  (7,  8).  Preliminary 
experiments  also  indicate  that  FcR  are  detectable  in  artificially  induced 
decidua,  thus  suggesting again  that  the presence of FcR-bearing cells in the 
deeidua  is  independent  of the  embryo  proper  and  may  be  a  programmed 
mechanism under hormonal control. 
FcR-bearing decidual cells may have some similarities  to FcR-positive cells 
described within tumors (44),  but it should be stressed that they are probably 
different from the FcR-bearing cells described in mouse and human placenta at 
later stages in pregnancy. These were reported to be chiefly fetal (trophoblastic) 
in origin (45,  46). Our observations that FcR-positive cells are found in similar 
amounts  in artificially  induced mouse decidua  2 at comparable  stages suggest 
that  no embryonic cells contribute  to the  FcR-bearing cell population  in the 
decidua of the pregnant mouse. 
Summary 
Mouse  decidual  cell  suspensions  from  day  6  to  day  8  of gestation  were 
prepared by enzymatic treatment  with collagenase and trypsin and tested for 
various membrane markers. 
(a)  Besides H-2 antigens,  Thy-1  antigens  are  present  on about 50% of the 
cells; this  may reflect the fibroblastic origin  of decidual cells or be a  marker 
expressed on some decidual cells possibly under hormonal control. 
(b) T or B lymphocytes, as defined by four Lyt antigens or surface immuno- 
globulins, are not present in significant amounts. 
(c) A substantial number of cells bearing receptors for the Fc portion of IgG 
(FcR) is detectable in the decidua, probably closely connected with trophoblast 
cells;  these  FcR-bearing  cells  may  act  in  preventing  excessive  invasion  of 
uterine tissue by trophoblast or could contribute to the protection of the embryo 
by interacting with maternal blocking antibodies and trephoblast. No receptors 
for  complement  were  detected,  even  after  16-20  h  in  culture  after  trypsin 
treatment. 
Received for publication 13 February 1978. 
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